FDA
approval
· 2021-05-13
FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
Summary
FDA approved a supplemental application to market a generic candesartan cilexetil and hydrochlorothiazide combination product for hypertension, from Solco Healt…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)